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Surgical Removal of Metastatic Renal Adenocarcinoma to the
Midbrain Tectum: A Case Report
Frank J. Tomecek, MD,* James I. Ausman, MD, PhD,* and Ghaus M. Malik, MD*

A patient with adenocarcinoma of the kidney metastatic lo the quadrigeminal plate of the midbrain
presented with acute obstructive hydrocephalus and early tonsillar herniation. Because the majority
of these carcinomas are resistant to radiation therapy, only limited treatment choices were available.
Initially, a ventriculoperitoneal shunt relieved the hydrocephalus and neurologic symptoms. After a
short course of improvement, with decompressed ventricles demonstrated hy postoperative computed
tomography, the patient developed additional neurologic signs, leading to the decision to excise the
metastatic tumor. Convalescence was complicated but the patient survivedfor six months, succumbing
to respiratory failure presumably caused by lung metastases. (Henry Ford Hosp Med J 1990;38:72-5)

E

xcision of a solitary intracranial metastasis can prolong and
improve the life of carefully selected patients (t-5). Over the
past several years uncontrolled retrospective studies of the effectiveness of surgical treatment for metastases have yielded conflicting results; some have shown benefit from surgery (3,6,7),
whereas others have not (8-10). A recent randomized prospective trial conducted by F^tchell et al (5) showed that patients with
cancer who undergo surgical resection plus radiotherapy for a
single brain metastasis live longer, have fewer recunences in the
brain, and have a better quality of life than similar patients
treated with radiotherapy atone. Nevertheless, the decision to
operate on a cerebral metastasis is controversial. Gushing (11)
and Dandy (12) were among the first to express their pessimism
conceming this form of therapy. A critical factor when comparing surgical intervention to other forms of treatment is the operative morbidity and mortality. Black (1) reported that operative
mortality ranged from 11% to 21% with additional operative
complications in 24% of patients undergoing excision of a solitary cerebral metastasis. Others reported lower mortality and
morbidity (13). In our unpublished series of craniotomies in 168
patients with metastatic carcinoma of the lung (performed between 1955 and 1986), the operative mortality was 6.7% and
morbidity was 15.3%. Recent improvement both in stereotactic
localization of tumors and in microsurgical technique has resulted in even lower operative mortality and morbidity (2).
An unresolved issue is the operative approach to a solitary
brainstem metastasis. Many believe that such tumors are inoperable because of their critical location and should be treated
by radiation therapy alone (14-18). We are aware of only two previous reports describing the surgical treatment for midbrain metastasis (19,20). We present a patient with renal adenocarcinoma
metastatic to the m i d b r a i n . Because an i n i t i a l ventriculoperitoneal (VP) shunt did not relieve the symptoms of acute
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obstmctive hydrocephalus, microsurgical excision of the tumor
was performed utilizing a carbon dioxide laser.

Case Report
In 1985 a 62-year-old man presented with a two-month history of
progressive diplopia, ataxic gait, generalized weakness, and somnolence. In 1983 he had undergone nephrectomy with lymph node dissection for adenocarcinoma of the kidney (hypernephroma). Subsequently he received chemotherapy which included progesterone. In
April 1984, a rib resection for recurrent cancer was followed by chemotherapy with a combination of vinblastine, adriamycin, and
Cytoxan. He recovered and was well for one year.
On this admission examination revealed diplopia on both right and
left lateral gaze. There was no papilledema. Extraocular movements
were intact except for mild nystagmus on lateral gaze. The pupils reacted equally to light and accommodation. Neurologic examination revealed poor short-term memory, dysmetria on the right with falling to
the right during tandem walking and performance of the Romberg test.
Computed tomography (CT) of the brain demonstrated a 1.5 cm enhancing mass involving the quadrigeminal plate and associated with
hydrocephalus (Figure). Four vessel cerebral angiography showed a
highly vascular, round, circumscribed mass which stained irregularly
and was located in the dorsal rostral aspect of the midbrain. The mass
displaced the precentral cerebellar vein posteriorly and the anterior
pontomesencephalic vein anteriorly indicating an intraaxial mass. In
view of the history, metastatic hypernephroma was suspected, although
a highly vascular primary lesion could not be excluded. Chest x-ray exhibited mild chronic obstructive pulmonary disease (COPD). Bone
scan suggested the pwssibility of a single metastatic lesion in the left
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Figure—Contrast-enhanced
CT (left) reveals 1.5 cm homogeneously enhancing mass in the midbrain tectum. Postoperative CT
(right) shows excision ofthe lesion and hypodense areas in the midbrain tectum and medial cerebellar hemisphere.
eighth rib, liver-spleen scan was negative, and CT of the chest showed
interstitial changes consistent with mild COPD. Presence of an enlarged lymph node in the mediastinum was questioned but no intraparenchymal metastases were evident.
Dexamethasone therapy was instituted, but because the patient failed
to improve he underwent placement of a VP shunt. The ventriculostomy
was placed in the left frontal hom in case a future right-sided craniotomy became necessary. Cerebrospinal fluid obtained at the time of
surgery was negative for infection or abnormal cytology.
Following placement of the VP shunt, the patient exhibited increased
short-term memory and was less somnolent. He was discharged home
on the sixth postoperative day receiving decreasing doses of dexamethasone.
One month later he retumed because of recurrent diplopia, worsening of right-sided dysmetria, ataxia, and somnolence. Examination disclosed a mild right abducens nerve palsy, persistent diplopia, and dysmetria oflherightarm and leg. CT showed normal-sized ventricles with
the VP shunt in place and an enlarged mass in the midbrain tectum extending to the superior medullary velum. Six weeks following VP shunt
placement the tumor was excised. Preoperatively the patient received
loading doses of dexamethasone and phenytoin, both of which were
continued postoperatively.

Operation
With the patient in the three-quarters prone, operated side down position, a right parietal-occipital craniotomy was performed (21). The patient received furosemide and mannitol, and 100 mL of cerebrospinal
fluid was drained through the spinal drain providing a slack brain. The
occipital lobe was retracted laterally with minimal pressure and the tentorium was exposed. Incision of the tentorium parallel to the straight
sinus exposed the superior cerebellum and vermis. A branch ofthe superior cerebellar artery was followed proximally leading to the cistem
ofthe quadrigeminal plate. The area between the vein of Galen and the
superior cerebellar artery contained a yellow amorphous mass. The tumor appeared to arise from the superior medullary velum and from the
inferior colliculus. Because it was highly vascular, the tumor was removed piecemeal using bipolar electrocautery and a carbon dioxide
laser thereby achieving adequate hemostasis. Although most of the tumor was resected, distinguishing tumor from the surrounding tissue
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was very difficult along its margins. The histological diagnosis was
consistent with metastatic renal adenocarcinoma of the clear cell type.

Postoperative course
After the operation the patient exhibited a mild left hemiparesis. Although lethargic, he was easily aroused and followed commands appropriately. He required ventilatory support. Postoperative CT showed collapse of the ventricular system with effacement of the subarachnoid
cisterns indicating increased intracranial pressure. Therefore, the patient was treated with mannitol, dexamethasone, and hyperventilation.
Ten days postoperatively, while still requiring mechanical ventilation,
he developed tracheobronchitis caused by hemophilus influenza and received a course of ampicillin. Five weeks postoperatively the patient
was extubated and transferred from the intensive care unit (ICU). His
prolonged stay in the ICU was primarily because of persistent increased
tracheobronchial secretions and a continued need for ventilatory assistance. A few days later the patient exhibited repetitive chewing
movements of his mouth and tongue and had a poor gag reflex. These
movements were thought to be facial myoclonus and clonazepam was
added to the increased dose of phenytoin. His postoperative course was
also complicated by a urinary tract infection and an allergic reaction,
probably to phenytoin, which was replaced by trihexyphenidyl and carbamazepine. With therapy, the patient became able to communicate
short sentences. He required assistance with feeding and ambulation
because of persistent moderate dysmetria of the right hand and leg. He
also displayed mild lefl hemiparesis.
CT prior to discharge showed the following: a hypodense lesion
along the right posterior midbrain probably represented the site of resection of the metastasis; an area of hypodensity in the right cerebellar
hemisphere suggested an infarct; and a small curvilinear zone of enhancement of the lateral aspect of the surgical bed possibly represented
postoperative enhancement, but residual tumor could not be excluded.
The ventricles were small but not collapsed, and no mass effect was
noted on the fourth ventricle.
Planned postoperative radiation therapy, 3,000 rads to the whole
brain followed by an additional 1,000 to 1,500 rads to the metastatic
tumor, was refused by the patient. He was discharged to a rehabilitation
center
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During the next three months the patient slowly improved in ambulation and speech but he developed a productive cough. A chest x-ray
demonstrated lung masses, presumably metastases, and he died at
home one month later from respiratory failure.

Discussion
Central nervous system (CNS) metastases occur in approximately 15% to 20% of patients dying of cancer, and one-third of
these are solitary (18,22). Solitary brainstem metastases, on the
other hand, are rare. By 1983, Delaney and Martinez (23) stated
that onty 40 cases had been adequately described and several of
these had been documented only by radiographs, not biopsy or
necropsy. The ratio of the number of cases of solitary CNS metastasis to the number of solitary brainstem metastasis is 32:1,
not significantly different from the ratio of weights of the invotved stmctures (18). Thus, the brainstem is probably no more
or less susceptible to metastasis than the remainder of the CNS.
When operating on the brainstem, the extent of the lesion
must be precisely defined. Because it can distinguish infiltrating
from welt circumscribed tumors, magnefic resonance imaging
(MRI) may be the study of choice for posterior fossa disease
(24,25). However, T2-weighted MRI images are less reliable
than contrast-enhanced CT in differentiating edema from tumor
mass (22). Contrast-enhanced CT images have been reported to
conelate closely with autopsyfindingsof solitary brainstem metastasis (17). Additional studies wUl be necessary before the
same can be said about enhanced MRI. Perhaps the most accurate way to differentiate tumor from sunounding edema is to assess glucose utilization by thetissueusing positron emission tomography (PET). Tumors exhibit high glucose utilization which
can be contrasted from the tower glucose utilization of surrounding edematous tissue. Unlike MRI or CT, PET can also be used
to differentiate recunent tumor from postradiotherapy necrosis
(26,27).
The neurosurgical approach to metastatic disease of the central nervous system includes tumor excision, decompression
and/or cerebrospinal fluid shunting, or stereotaxic biopsy and
interstitial radiation therapy (28). Altematively, one may choose
not to operate but to attempt palliation with radiation. The prospective randomized study of Patchell et al (5) has shown the
advantages of surgical treatment for singte metastasis to the
brain. The indicafions for surgical treatment of single metastasis
to the brainstem are not established. Tomita and Wetzel (17) as
wett as Weiss and Richardson (18) advised against operation for
brainstem metastasis because of the critical location of the
tumor.
To our knowledge, surgical excision of brainstem metastasis
has been described only in two other cases. Hacker and Fox (19)
were the first to report an attempt at surgical excision of a solitary brainstem metastasis in 1980. Their indications for surgery
were to establish a diagnosis and because of increasing mass effect and fourth ventricle shift. They agreed with the radiologic
indications for exploration of brainstem neoplasms recommended by Lassman (29); 1) marked hydrocephalus, 2) more
than slight deviation of the fourth ventricle and aqueduct from
the midline, and 3) a filling defect ofthe fourth ventricle. Tobler
et al (20) first reported the complete excision of metastatic ade-

74 Henry Ford Hosp Med J—Vol 38. No 1, 1990

nocarcinoma of the lung to the midbrain. Their decision to operate was based upon failure of radiation to palliate the patient's
symptoms, the increasing size of the mass, lack of apparent active primary disease, the patient's generally favorable medical
condition, and the long latent period which preceded the appearance of cerebral metastasis (1,18), With advanced microsurgery and the use of laser vaporization, Tobler et at (20) could
decompress space occupying metastasis to the brainstem and
obtain excellent postoperative results, Kelly et at (2) described
stereotactic localization and successful excision of an alveolar
cell carcinoma of the lung metastatic to the right middle cerebellar peduncle There is yet no report of stereotactic biopsy and
interstitial radiation, but if the radiation could be confined to the
tumor, this approach might be very successful,
In our case the patient presented with hydrocephalus, right
cerebellar dysfunction probably due to involvement of the right
superior cerebellar peduncle, a mass effect on the brainstem,
and early tonsillar hemiation. He had a well-differentiated carcinoma of the kidney. Metastases of these neoplasms often exhibit indolent behavior after ablation of the source (30,31). Renal cell carcinomas are relatively resistant to radiation therapy
(1,28). Although surgical excision was considered, the lower
risk shunting procedure was chosen initially to obtain symptomatic relief from obstmctive hydrocephalus. However, when
the symptoms worsened one month postoperatively, we proceeded to excise the tumor. Survival with metastases unprecedented in other tumors has been documented in hypemephroma
(32) and even cure after removal of a cerebral hemisphere metastasis has been recorded (33).
These unique characteristics of metastatic hypemephroma influenced our decision toward surgery. Other indications for surgical excision were the uncertain diagnosis, the long latent interval between diagnosis of the primary tumor and detection of the
brain metastasis, the potential for the increasing mass to produce severe neurologic disability or death, the demonstrated
fourth ventricle shift, and the low tumor burden elsewhere in the
body suggesting the potential for protonged survival. Unfortunately, the patient's general medical condition required a prolonged hospital stay although his neurologic status was stable
postoperafively and did not contribute to his prolonged hospital
course. Very likely, undetected pulmonary metastases worsened
his already compromised pulmonary function and contributed
to his death.
Nevertheless, with cunent microsurgical and stereotactic advances, brainstem metastasis can be accessible and treated with
surgical excision.
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